Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 17 of 17 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Antigenomycs Inc. | Activity: Research and Development | Company Description Antigenomycs is commercializing antigenome technology to measure complex antibody responses in health and disease. | Location Durham |
| |
Company BioCytics Inc. | Activity: Research and Development | Company Description BioCytics researches and develops personalized cellular immunotherapy cancer therapies with the latest technology and equipment. BioCytics also offers contract R&D and is co-located with its sister company, the Carolina BioOncology Institute. | Location Huntersville |
| |
Company Cell Microsystems Inc. | Activity: Research and Development | Company Description Cell Microsystems develops, manufactures, and markets products for single cell workflows including CRISPR gene editing, stem cell research, organoid studies, cell line development and antibody discovery. | Location Durham |
| |
Company Cellective BioTherapy Inc. | Activity: Research and Development | Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. | Location Chapel Hill |
| |
Company Dualogics LLC | Activity: Research and Development | Company Description Dualogics researches and develops bispecific antibody products based on their proprietary OrthoMab platform. | Location Durham |
| |
Company GEM Tox Labs | Activity: Research and Development | Company Description GEM Tox Labs conducts research focused on the role of MicroRNA molecules in cancer. | Location Greenville |
| |
Company Grid Therapeutics LLC | Activity: Research and Development | Company Description Grid Therapeutics is developing cancer therapeutics that utilize a unique platform that develops human-derived antibodies for the treatment of multiple cancer types. | Location Durham |
| |
Company Immunovant Inc. | Activity: Research and Development | Company Description Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases. | Location Durham |
| |
Company Inhalon Biopharma Inc. | Activity: Research and Development | Company Description Inhalon Biopharma is a clinical-stage, inhaled immunotherapy company developing prophylactic and therapeutic antibodies (mAb) for acute respiratory infections. Inhalon has a patented proprietary muco-trapped mAb platform technology with broad IP coverage of inhaled mAb delivery. | Location Morrisville |
| |
Company Isolere Bio Inc. | Activity: Research and Development | Company Description Isolere Bio is developing novel, non-chromatographic technologies for the purification of biologics such as antibodies, gene delivery vectors and personalized cell therapies. | Location Durham |
| |
Company Mucommune LLC | Activity: Research and Development | Company Description Mucommune is developing a platform using monoclonal antibodies and mucus to reinforce the mucus barrier for female reproductive health. | Location Durham |
| |
Company On.Target Molecules Biotech Inc. | Activity: Research and Development | Company Description O.TM Biotech is developing anti-cancer monoclonal antibodies using a novel technology platform to accelerate advancements in cancer therapeutics. | Location Wilmington |
| |
Company OncoTAb Inc. | Activity: Research and Development | Company Description OncoTAb develops a continuum of products from early detection to treatment of epithelial cancers. Current products on the market and under development address unmet needs in the detection and treatment of pancreatic cancer as well as triple negative and metastatic breast cancer. | Location Charlotte |
| |
Company Relevant Biosciences Inc. | Activity: Research and Development | Company Description Relevant Bio develops natural antibody-based cancer therapeutics. | Location Raleigh |
| |
Company SeaTox Research Inc. | Activity: Research and Development | Company Description SeaTox Research develops bioassays for the detection of marine toxins and conducts pharmaceutical development through bioprospecting. | Location Wilmington |
| |
Company Solve Therapeutics Inc. | Activity: Research and Development | Company Description Solve Therapeutics develops antibody-drug conjugates (ADC) and antibody-radionuclide conjugates (ARC) for oncology patients. | Location Durham |
| |
Company United Therapeutics Corp. (RTP HQ) | Activity: Research and Development | Company Description United Therapeutics develops and commercializes products to treat cardiopulmonary diseases, infectious diseases and cancer. | Location Research Triangle Park |